Your browser doesn't support javascript.
loading
Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma.
Huwyler, Fabrizio; Kunz, Rebekka; Bacher, Ulrike; Hoffmann, Michèle; Novak, Urban; Daskalakis, Michael; Banz, Yara; Pabst, Thomas.
Affiliation
  • Huwyler F; Department of Medical Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland.
  • Kunz R; Department of Medical Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland.
  • Bacher U; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
  • Hoffmann M; Department of Medical Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland.
  • Novak U; Department of Medical Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland.
  • Daskalakis M; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
  • Banz Y; Institute of Pathology, Inselspital, University of Bern, 3008 Bern, Switzerland.
  • Pabst T; Department of Medical Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland.
Cancers (Basel) ; 15(7)2023 Mar 31.
Article in En | MEDLINE | ID: mdl-37046753
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2023 Type: Article Affiliation country: Switzerland
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2023 Type: Article Affiliation country: Switzerland